Chordoma - 21 Studies Found

Active, not recruiting : Nilotinib With Radiation for High Risk Chordoma
: Chordoma
: 2011-07-28
:
  • Drug: Nilotinib Orally, daily

Active, not recruiting : Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
: Chordoma
: 2010-07-28
: Drug: Imatinib + LBH589 Escalating doses of imatinib and LBH589 will be administered.
Completed : Efficacy and Safety of Imatinib in Chordoma
: Chordoma
: 2005-09-07
: Drug: imatinib
Active, not recruiting : Proton Beam Therapy for Chordoma Patients
: Chordoma
: 2007-07-02
:
  • Radiation: Proton Beam Therapy

Completed : Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
: Chordoma
: 2006-06-19
Completed : Chordoma Family Study
: Chordoma
: 2006-12-12
Completed : Ion Irradiation of Sacrococcygeal Chordoma
: Sacral Chordoma
: 2013-03-09
:
  • Radiation: protons Treatment i
Not yet recruiting : CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma
: Chordoma
: 2017-03-31
: Drug: Palbociclib application on 21 consecutive days of a 28 days cycle
Completed : Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
: Chordoma
: 2016-12-02
:
  • Other: Randomized Cohort Surgi
Not yet recruiting : Afatinib in Locally Advanced and Metastatic Chordoma
: Chordoma
: 2017-02-10
: Drug: Afatinib Afatinib will be given daily in a dose of 40 mg orally in a 4 week cycle until disease pr
Next >>>